Normal Saline 0.9% Infusion Solution Bag — Competitive Intelligence Brief

Normal Saline 0.9% Infusion Solution Bag (Normal Saline 0.9% Infusion Solution Bag) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid fluid / Electrolyte replacement solution. Area: Critical Care / Fluid and Electrolyte Management.

marketed Crystalloid fluid / Electrolyte replacement solution Critical Care / Fluid and Electrolyte Management Small molecule

Target snapshot

Normal Saline 0.9% Infusion Solution Bag (Normal Saline 0.9% Infusion Solution Bag) — Vanderbilt University Medical Center. Normal saline provides isotonic fluid replacement to maintain hydration and electrolyte balance.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Normal Saline 0.9% Infusion Solution Bag TARGET	Normal Saline 0.9% Infusion Solution Bag	Vanderbilt University Medical Center	marketed	Crystalloid fluid / Electrolyte replacement solution
Sterile isotonic saline solution	Sterile isotonic saline solution	Hospital Italiano de Buenos Aires	marketed	Crystalloid fluid / Electrolyte replacement solution
saline 09%	saline 09%	Vinmec Healthcare System	marketed	Crystalloid fluid / Electrolyte replacement solution
Intravenous 0.9% Sodium Chloride	Intravenous 0.9% Sodium Chloride	GCP-Service International West GmbH	marketed	Crystalloid fluid / Electrolyte replacement solution
Isotonic NaCl	Isotonic NaCl	Hvidovre University Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution
% 0.9 Saline solution	% 0.9 Saline solution	Kecioren Education and Training Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution
Isotonic sodium chloride 0.9 percent	Isotonic sodium chloride 0.9 percent	Rigshospitalet, Denmark	marketed	Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid fluid / Electrolyte replacement solution class)

1. Dr. Waseem Ullah · 1 drug in this class
2. Fayoum University Hospital · 1 drug in this class
3. GCP-Service International West GmbH · 1 drug in this class
4. Hospital Central "Dr. Ignacio Morones Prieto" · 1 drug in this class
5. Hospital Italiano de Buenos Aires · 1 drug in this class
6. Hvidovre University Hospital · 1 drug in this class
7. Hédi Chaker Hospital · 1 drug in this class
8. Kecioren Education and Training Hospital · 1 drug in this class
9. Krankenhaus Barmherzige Schwestern Linz · 1 drug in this class
10. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class